OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+26.4%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$124M
AUM Growth
+$124M
(+36%)
Cap. Flow
+$34.8M
Cap. Flow
% of AUM
27.98%
Top 10 Holdings %
Top 10 Hldgs %
97.13%
Holding
24
New
3
Increased
6
Reduced
6
Closed
3
Top Buys
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$13M |
| 2 |
GeneDx Holdings
WGS
|
$8.66M |
| 3 |
Ardelyx
ARDX
|
$8.58M |
| 4 |
Biohaven
BHVN
|
$4.84M |
| 5 |
EyePoint Pharmaceuticals
EYPT
|
$1.25M |
Top Sells
| 1 |
Teladoc Health
TDOC
|
$2.43M |
| 2 |
QuidelOrtho
QDEL
|
$927K |
| 3 |
AGEN
Agenus
AGEN
|
$203K |
| 4 |
VTNR
Vertex Energy, Inc
VTNR
|
$170K |
| 5 |
Pacific Biosciences
PACB
|
$77.9K |
Sector Composition
| 1 | Healthcare | 99.01% |
| 2 | Consumer Discretionary | 0.99% |
| 3 | Energy | 0% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Biohaven
BHVN
$1.63B
| $44M | 29.25% | 804,850 +88,423 | +12% | +$4.84M |
|
|
SWTX
2
DELISTED
SpringWorks Therapeutics
SWTX
| $20.8M | 13.79% | 421,583 +264,500 | +168% | +$13M |
|
|
3
Ardelyx
ARDX
$1.53B
| $14.9M | 9.89% | 2,039,700 +1,175,000 | +136% | +$8.58M |
|
|
4
GeneDx Holdings
WGS
$3.72B
| $10.3M | 6.83% | 1,126,607 +948,253 | +532% | +$8.66M |
|
|
5
EyePoint Pharmaceuticals
EYPT
$797M
| $9.55M | 6.34% | 461,857 +60,300 | +15% | +$1.25M |
|
|
6
QuidelOrtho
QDEL
$1.95B
| $7.54M | 5.01% | 157,201 -19,343 | -11% | -$927K |
|
|
7
Pacific Biosciences
PACB
$393M
| $5.09M | 3.38% | 1,356,026 -20,769 | -2% | -$77.9K |
|
8
Forian
FORA
$61.3M
| $4.5M | 2.99% | 1,355,807 -12,260 | -0.9% | -$40.7K |
|
9
BioCryst Pharmaceuticals
BCRX
$1.74B
| $2.72M | 1.81% | 535,558 | – | – |
|
|
IMMP
10
Immutep
IMMP
$234M
| $1.32M | 0.87% | 564,879 +48,449 | +9% | +$113K |
|
11
CAVA Group
CAVA
$7.83B
| $1.23M | 0.82% | +17,600 | New | +$1.23M |
|
|
AGEN
12
Agenus
AGEN
$133M
| $619K | 0.41% | 1,066,963 -350,000 | -25% | -$203K |
|
|
WBA
13
DELISTED
Walgreens Boots Alliance
WBA
| $596K | 0.4% | +27,500 | New | +$596K |
|
14
Biogen
BIIB
$19.4B
| $520K | 0.35% | 2,412 | – | – |
|
|
OPTN
15
DELISTED
OptiNose
OPTN
| $475K | 0.32% | +325,000 | New | +$475K |
|
16
Biodesix
BDSX
$62.6M
| $43.4K | 0.03% | 30,351 -30,588 | -50% | -$43.7K |
|
|
AXDX
17
DELISTED
Accelerate Diagnostics
AXDX
| $41.7K | 0.03% | 42,101 -69,474 | -62% | -$68.8K |
|
|
DMTK
18
DELISTED
DermTech, Inc. Common Stock
DMTK
| $33.5K | 0.02% | 47,687 | – | – |
|
19
MiNK Therapeutics
INKT
$64.4M
| – | – | -36,898 | Closed | -$39.5K |
|
20
Palantir
PLTR
$372B
| – | – | 0 | – | – |
|
21
STAAR Surgical
STAA
$1.36B
| – | – | 0 | – | – |
|
|
22
Teladoc Health
TDOC
$1.37B
| – | – | -112,861 | Closed | -$2.43M |
|
23
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | 0 | – | – |
|
|
VTNR
24
DELISTED
Vertex Energy, Inc
VTNR
| – | – | -50,000 | Closed | -$170K |
|